examples of glp 1 analogues GLP-1 in the Neurobiology Addiction: Translational Insights and Therapeutic Perspectives Glucagon-Like Peptide-1: New Regulator in

In SURMOUNT-3, after a 12-week lifestyle intervention (including a low-calorie diet and exercise), participants treated with Tirzepatide lost an average of 21.1% of their body weight , while the placebo group saw a weight increase of 3.3%

We dig into: Lilly's decision to stop disclosing its Phase 1 pipeline The Camurus fluid crystal technology deal and what it means for long-acting GLP-1s Eloralintide Lilly's selective amylin agonist and potential dark horse in obesity medicine How eloralintide compares to Novo Nordisk's cagrilintide Why the future of obesity treatment is a toolbox, not a scoreboard The access crisis: prior authorizations, insurance exclusions, Medicare, and Medicaid coverage gaps Retatrutide , quintuple agonists, and what's coming out of ADA 2026 If you're on Zepbound , Wegovy , Ozempic , or any GLP-1 medication or you're waiting for the next generation of obesity drugs this episode is for you

Discuss these risks with your provider

Features of hepatic and skeletal muscle insulin resistance unique to type 1 diabetes

Acetyl-l-Carnitine in the Treatment of Peripheral Neuropathies: A Narrative Review